Boditech Med Inc. (KOSDAQ:206640)

Boditech Med Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	320,431	368,764	450,360	225,170	382,205	545,546
Market Cap Growth	-16.27%	-18.12%	100.01%	-41.09%	-29.94%	146.19%
Enterprise Value	283,963	321,766	398,068	182,995	329,122	520,102
Last Close Price	14710.00	16622.29	20019.69	10009.85	16167.45	22524.33
PE Ratio	12.59	13.53	17.36	9.32	8.62	11.99
Forward PE	9.88	23.45	23.45	23.45	23.45	23.45
PS Ratio	2.14	2.67	3.36	1.91	2.42	3.79
PB Ratio	1.37	1.65	2.28	1.29	2.37	4.33
P/TBV Ratio	1.48	1.79	2.47	1.42	2.61	4.73
P/FCF Ratio	23.46	27.41	15.17	28.84	12.06	13.45
P/OCF Ratio	12.71	14.82	13.13	9.76	7.66	12.22
EV/Sales Ratio	1.90	2.33	2.97	1.55	2.09	3.61
EV/EBITDA Ratio	7.25	9.31	10.91	5.69	5.68	7.28
EV/EBIT Ratio	9.53	12.31	14.09	7.42	6.34	7.88
EV/FCF Ratio	20.79	23.92	13.41	23.44	10.38	12.82
Debt / Equity Ratio	0.04	0.05	0.05	0.05	0.04	0.10
Debt / EBITDA Ratio	0.23	0.32	0.29	0.28	0.12	0.17
Debt / FCF Ratio	0.62	0.82	0.36	1.14	0.22	0.29
Asset Turnover	0.58	0.57	0.63	0.61	0.89	1.09
Inventory Turnover	1.70	1.62	1.72	1.48	2.07	2.41
Quick Ratio	3.89	3.38	3.83	5.18	3.51	2.84
Current Ratio	5.69	4.96	5.09	7.28	4.84	3.65
Return on Equity (ROE)	11.29%	12.95%	14.33%	15.05%	32.99%	47.55%
Return on Assets (ROA)	6.84%	6.77%	8.34%	7.95%	18.25%	31.17%
Return on Capital (ROIC)	7.38%	7.39%	9.02%	8.77%	21.21%	35.70%
Return on Capital Employed (ROCE)	11.80%	11.50%	14.10%	13.70%	31.50%	50.70%
Earnings Yield	7.97%	7.39%	5.76%	10.73%	11.61%	8.34%
FCF Yield	4.26%	3.65%	6.59%	3.47%	8.29%	7.44%
Dividend Yield	1.02%	0.90%	1.00%	1.50%	1.24%	0.89%
Payout Ratio	12.80%	16.12%	12.70%	17.68%	10.39%	2.52%
Buyback Yield / Dilution	0.58%	0.13%	1.77%	2.41%	0.47%	-0.14%
Total Shareholder Return	1.61%	1.03%	2.77%	3.91%	1.70%	0.75%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.